Jennifer J. Wheler, MD
UT MD Anderson Cancer Center · M.D. Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jennifer J. Wheler, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:01 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT00939172 · TTP607 in Refractory Solid MalignanciesM.D. Anderson Cancer Center · withdrawn · Advanced Cancers, Lymphoma · study chair
- Ph1NCT00895128 · Study of Erlotinib in Combination With DasatinibM.D. Anderson Cancer Center · completed · Advanced Cancer · principal investigator
- Ph1NCT00895362 · Erlotinib in Combination With CetuximabM.D. Anderson Cancer Center · completed · Advanced Cancers · principal investigator
- Ph1NCT00895687 · Study of Erlotinib in Combination With BortezomibM.D. Anderson Cancer Center · completed · Advanced Cancer · principal investigator
- Ph1NCT00591682 · MSX-122 Administered Orally in Patients With Refractory Metastatic or Locally Advanced Solid TumorsMetastatix, Inc. · suspended · Solid Tumors · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.